Current status of endomyocardial biopsy

Aaron M From1, Joseph J Maleszewski, Charanjit S Rihal

  • 1Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA..

Mayo Clinic Proceedings
|October 29, 2011
PubMed
Summary

Endomyocardial biopsy (EMB) is crucial for monitoring heart transplant rejection. However, its use for diagnosing other heart conditions in non-transplant patients is debated, as noninvasive methods are often sufficient.